WEEKLY e-ALERT  [ BASIC EDITION ]
Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical sector. Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most MNC pharma companies, leading CROs, investment banks, consulting firms active in China as well as relevant industry associations and government agencies.

Note: To view full text of free articles, you need to register as a basic member first and then log in. To view premium articles, you need to subscribe to Pharma China as a premium member. For more information or subscription, please contact info@pharmachinaonline.com. If you wish to unsubscribe from this e-Alert, please reply this e-mail with "Remove" in the subject line.
Editor´s Picks
Production of Trustworthy Real World Data and Evidence in China(11/7/2018 )  (Premium)
The Market
Faster Aging of Population Boosts China's Human Vaccine Industry(11/6/2018 )  (Premium)
Industry News
Merck KGaA Paves the Way for its Innovation Hub in Southern China(11/11/2018 )  (Premium)
Performance of Chinese Pharmaceutical Industry on Steady Growth in 3Qs/2018(11/9/2018 )  (Premium)
Amyris Further Expands Relationship with Yifan Pharma(11/8/2018 )  (free)
Ascendis Forms Chinese JV for Endocrinology Rare Disease Therapies(11/8/2018 )  (Premium)
Leading Chinese Pharma Companies by R&D Spending in 3Qs/2018(11/8/2018 )  (Premium)
GE to Produce Single-Use Consumables in China thru Collaboration with Wego(11/7/2018 )  (free)
Eisai Commences Full-Scale Operation of New Suzhou Plant in China(11/7/2018 )  (Premium)
Pfizer Makes Bold Moves to Maximize China Business under New Leadership(11/7/2018 )  (Premium)
Roche Expects to Launch Five More Drugs in China in the next two years(11/7/2018 )  (Premium)
Lilly and NextCure Announce Collaboration to Discover and Develop Novel Immuno-Oncology Medicines(11/7/2018 )  (free)
Zambon Boosts Export of Fluimucil to China in Partnership with AstraZeneca(11/7/2018 )  (Premium)
EyePoint Pharma and Ocumension Sign Exclusive License for Uveitis in Greater China(11/5/2018 )  (Premium)
Mapi Pharma Closes $10M Investment by Zhejiang Jingxin Pharma(11/5/2018 )  (Premium)
Automation Could Help China Capture Pharma Manufacturing Lead(11/5/2018 )  (Premium)
Most Domestically-listed Medical/Pharma Companies Report Positive Results in Q3 of 2018(11/5/2018 )  (Premium)
Regulatory News
NMPA Issues Guidelines for Clinical Trials of Mental and Bipolar Disorder Drugs(11/8/2018 )  (Premium)
NMPA Issues New Announcement (2018#86) for Clinical Data Self-Inspection(11/8/2018 )  (Premium)
Shanghai Promotes Biopharma Innovation with New Measures(11/7/2018 )  (Premium)
CDE Issues Notice Over Change of Priority Review Publication Process(11/7/2018 )  (Premium)
NMPA Releases List of Reference Formulations for Generic Drug Equivalence Studies (18th Batch)(11/6/2018 )  (Premium)
NMPA Launches New Official Website(11/5/2018 )  (Premium)
General Health
China Step Up Crackdown on Medical Frauds by Charities(11/11/2018 )  (Premium)
China Step Up Crackdown on Medical Frauds by harities face severe penalties(11/11/2018 )  (Premium)
Legal/IPR News
Chinese Lawyer Sues Yunnan Baiyao over False Advertising(11/7/2018 )  (Premium)
People in the News
Recent Executive Moves(11/9/2018 )  (Premium)
Other News
China to Launch New Tech Bourse in Shanghai(11/7/2018 )  (Premium)
© Wicon International GroupˇˇSupport by: www.heightow.com Home | Site map | Contact Us | Links